SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-22-007390
Filing Date
2022-03-28
Accepted
2022-03-28 16:07:26
Documents
95
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K navb20211231_10k.htm   iXBRL 10-K 2491788
2 EXHIBIT 21.1 ex_349097.htm EX-21.1 4951
3 EXHIBIT 23.1 ex_350834.htm EX-23.1 3064
4 EXHIBIT 24.1 ex_349098.htm EX-24.1 12147
5 EXHIBIT 31.1 ex_349099.htm EX-31.1 8465
6 EXHIBIT 31.2 ex_349100.htm EX-31.2 8503
7 EXHIBIT 32.1 ex_349101.htm EX-32.1 4287
8 EXHIBIT 32.2 ex_349102.htm EX-32.2 4361
14 chart1.jpg GRAPHIC 42419
15 footer001.jpg GRAPHIC 10334
16 logo001.jpg GRAPHIC 7175
  Complete submission text file 0001437749-22-007390.txt   10530200

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA navb-20211231.xsd EX-101.SCH 90513
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20211231_cal.xml EX-101.CAL 49355
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20211231_def.xml EX-101.DEF 697079
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20211231_lab.xml EX-101.LAB 545444
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20211231_pre.xml EX-101.PRE 724739
89 EXTRACTED XBRL INSTANCE DOCUMENT navb20211231_10k_htm.xml XML 1470685
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 22775532
SIC: 2835 In Vitro & In Vivo Diagnostic Substances